Back to Agenda
Advancing the Science of Patient Input: How are WE doing? Multi-Stakeholder Perspective
Session Chair(s)
Pujita Vaidya, MPH
Director, Regulatory Science and Policy, Sanofi, United States
This forum will present current efforts and future opportunities to advance the incorporation of patient input into the medical product lifecycle. A panel of experts will discuss examples of how patient input have informed medical product decisions.
Learning Objective : Discuss current progress by key stakeholders in incorporating patient input into medical product development and regulatory decision-making; Discuss approaches and best practices to collect, analyze, assess quality, and present patient input; Identify opportunities for further enhancing the incorporation of patient input across the medical product lifecycle.
Speaker(s)
Michelle Tarver, MD, PHD
Deputy Center Director for Transformation, CDRH, FDA, United States
Panelist
David S. Reasner, PHD
Director, Division of Clinical Outcome Assessment, OND, CDER, FDA, United States
Panelist
Annie Kennedy
Chief of Policy, Advocacy, and Patient Engagement, EveryLife Foundation for Rare Diseases, United States
Panelist
Jessica S. Scott, JD, MD
President, Legacy Health Strategies , United States
Panelist
Robyn T. Carson, MPH
Vice President, Patient-Centered Outcomes Research, AbbVie, United States
Panelist
Have an account?